Opening Bell Analysts Research Calls for Monday, April 17
This report was sent to Briefing.com subscribers earlier today. Research calls posted earlier this morning are available here. Upgrades: > Astellas Pharma (ALPMY) upgraded to Buy from Neutral at Citigroup > Enphase Energy (ENPH) upgraded to Overweight from Neutral at…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Research calls posted earlier this morning are available here.
Upgrades:
> Astellas Pharma (ALPMY) upgraded to Buy from Neutral at Citigroup
> Enphase Energy (ENPH) upgraded to Overweight from Neutral at Piper Sandler; tgt $255
> Murphy Oil (MUR) upgraded to Buy from Hold at Jefferies; tgt $41
> NN Group (NNGPF) upgraded to Buy from Hold at Berenberg
Downgrades:
> Cushman & Wakefield (CWK) downgraded to Neutral from Buy at UBS; tgt lowered to $10
> Ecolab (ECL) downgraded to Underperform from Neutral at BofA Securities; tgt $162
> Essilor International (ESLOY) downgraded to Mkt Perform from Outperform at Bernstein
> EverQuote (EVER) downgraded to Perform from Outperform at Oppenheimer
> Fortum Oyj (FOJCY) downgraded to Neutral from Buy at Citigroup
> Givaudan SA (GVDNY) downgraded to Hold from Buy at Berenberg
> Valero Energy (VLO) downgraded to Hold from Buy at Tudor, Pickering, Holt & Co.
> Westlake Corporation (WLK) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $134
Others:
> Aravive (ARAV) assumed with a Buy at BTIG Research; tgt $12
> Aura Biosciences (AURA) assumed with a Buy at BTIG Research; tgt $38
> Commscope (COMM) placed on Positive Catalyst Watch at JP Morgan
> Helen of Troy (HELE) initiated with a Neutral at UBS; tgt $99
> Kimco Realty (KIM) placed on Tactical Outperform List at Evercore ISI
> Okta (OKTA) initiated with a Buy at UBS; tgt $100
> Paratek Pharma (PRTK) assumed with a Buy at BTIG Research; tgt $24
> Rani Therapeutics (RANI) assumed with a Buy at BTIG Research; tgt $24
> SPX Corp (SPXC) resumed with an Outperform at William Blair; tgt $80
> Symbotic (SYM) initiated with a Buy at Craig Hallum; tgt $35
> Syndax Pharmaceuticals (SNDX) assumed with a Buy at BTIG Research; tgt $34
> Toro (TTC) initiated with a Market Perform at Northland Capital; tgt $110
> Zoom Video (ZM) placed on 90-day Downside Catalyst Watch at Citigroup
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.